Hologic develops and supplies diagnostic products, medical imaging systems, and surgical products for womens health. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides molecular diagnostic assays, viral load assays, and tests for vaginal infections and SARS-CoV-2 detection. Hologic also offers breast cancer care solutions, including 3D digital mammography systems and image analytics software. The company provides surgical products, such as hysteroscopic tissue removal and endometrial ablation systems. Additionally, it offers dual energy X-ray systems and mini C-arm systems for minimally invasive orthopedic procedures. Hologic sells its products through various channels and is headquartered in Marlborough, Massachusetts.
Indicator | Value |
---|---|
PER | 18.8 |
EV/EBITDA | 11.3 |
Price/Free Cash Flow' | 13.0 |
ROIC | 16.8% |
Net Debt/EBITDA | 0.3 |